| 11:30 - 18:45 | EP Traces Course | Hall 8a |
| 14:00 - 15:30 | Arrhythmia Alliance 1 Symposia – New Frontiers and Challenges in Pacing | Hall 8b |
| 14:00 - 15:30 | Masterclass Devices 1 – Lead Extraction in 2026 – State of the Art Review | Executive Room 1 |
| 14:00 - 15:30 | Oral Abstracts – Evolving Frontiers and Arrhythmia Mechanisms | Executive Room 2 |
| 16:00 - 17:30 | AF Association 1 Symposia – Looking at AF Management Across the Population – From Start to Finish! | Hall 8b |
| 16:00 - 17:30 | Strategies for VT Ablation: Mapping, Ablation Tools, and Procedural Workflows | Executive Room 1 |
| 16:00 - 17:30 | Oral Abstracts - Arrhythmia Clinical | Executive Room 2 |
| Chair: Dr Dewi Thomas, Dr Ruairidh Martin, Dr Simon Modi | Swansea, UK, Newcastle Upon Tyne, UK, Liverpool, UK | |||
|---|---|---|---|---|
| 11:30 | Welcome, course objectives and ‘How to approach the unknown tracing’ | |||
| 11:45 | EP traces session 1 - 4 (please note there will be lunch, followed by 1 x break throughout the day) | |||
| 18:45 | Close |
| Chair: Dr Mark Tanner, Dr Nadine Ali | Chichester, UK, High Wycombe, UK | |||
|---|---|---|---|---|
| 14:00 | Should I be aiming for physiological atrial pacing? | Dr Badrinathan Chandrasekaran | Swindon, UK | |
| 14:10 | My approach to Bachmann’s bundle pacing | Dr Ahran Arnold | London, UK | |
| 14:20 | Current state of the art in leadless pacing: which patients, what approach? | Dr Jenny Chuen | Nottingham, UK | |
| 14:30 | Leadless service: enhancing equity and ease of access | Dr Badrinathan Chandrasekaran | Swindon, UK | |
| 14:40 | Which pacing approach should I use for bradycardia indication and LVEF between 35–50%? (recorded presentation) | Prof Valentina Kutyifa | Rochester, US | |
| 14:50 | Extract or jail? – Managing pacing leads prior to tricuspid valve intervention | Prof Aldo Rinaldi | London, UK | |
| 15:00 | CIEDs upgrades and downgrades: what does EHRA advise? | Dr Daniel Keene | London, UK | |
| 15:10 | Final discussion | |||
| 15:30 | Close |
| Chair: Dr Lisa Leung, Prof Mark Gallagher | London, UK, London, UK | |||
|---|---|---|---|---|
| 14:00 |
Who needs a lead extraction procedure – indications in 2026
Infection, malfunctioning systems, preserving access and SVC syndrome Abandon or extract? – initiating the debate on abandonment versus extraction Review of the evidence and guidelines |
Dr Zia Zuberi | London, UK | |
| 14:20 |
Preparation for extractions – what information is vital for extractors from non-extractors?
The dilemma of re-implantation – externalised TPW, Micra, CRT vs CSP and contralateral implant in the same sitting Review of the evidence and cases |
Dr Jonathan Behar | London, UK | |
| 14:40 |
Modern TLE – advances in lead extraction techniques
Tandem, jugular, femoral and snaring techniques – case-based discussion |
Dr Zaki Akhtar | London, UK | |
| 15:00 |
Safety in transvenous lead extraction – associated risks, complications and strategies to reduce overall risk
SVC balloon, cardiopulmonary bypass, AngioVac for large vegetations/clots and surgical backup in the room or on standby What to do in pacing-dependent patients – the St George’s temporary pacing system |
Dr Manav Sohal | London, UK | |
| 15:20 | Final discussion | |||
| 15:30 | Close |
| Chair: Dr Gavin Chu, Dr Shamil Yusuf | Blackpool, UK, Coventry, UK | |||
|---|---|---|---|---|
| 14:00 | Concordant electrical and structural atrial remodelling confers 26 fold higher odds of atrial fibrillation: a four-phenotype classification | Sadees Clarance Chandran | Dalian, CN | |
| 14:15 | Clinical characteristics and ablation outcomes in patients with right atrial cardiomyopathy | Jing Hu | Nanchang, CN | |
| 14:30 | A high-definition unipolar intracardiac electrogram processing algorithm | Qindong Zheng | London, UK | |
| 14:45 | Association of GLP-1 receptor agonist therapy with atrial fibrillation risk in patients with stage 3–4 chronic kidney disease | Ranokhon Igamberdiyeva | Tashkent, UZ | |
| 15:00 | Explainable machine learning for AF detection using ECG remodelling markers: false positives reveal subclinical atrial myopathy | Sadees Clarance Chandran | Dalian, CN | |
| 15:15 | Tau20-RETROmapping system reliably identifies organised wavefronts during atrial fibrillation to produce live beat-to-beat activation maps | Fatima Nadeem | London, UK | |
| 15:30 | Close |
| Chair: Dr Milena Leo, Dr Shouvik Haldar | Portsmouth, UK, London, UK | |||
|---|---|---|---|---|
| 16:00 | Pulsed field ablation for PVI: hype, evidence, and real-world adoption | Dr Davide Fabbricatore | London, UK | |
| 16:15 | Antiarrhythmic drugs in real-world practice: Expert guidance for understudied clinical scenarios from the new HRS scientific statement | Dr Daniel Morin | San Francisco, US | |
| 16:30 | The arrhythmia nurse specialist’s role in modern AF pathways | Dr Angela Griffiths | Oxford, UK | |
| 16:45 | Population screening for AF (recorded presentation) | Dr Damian Redfearn | Ottawa, CA | |
| 17:00 | Revolutionising the Standard of Care: AI-Driven 12-Lead ECG Acquisition via the Kardia 12L System | Dr Yassir Javaid | Northampton, UK | |
| 17:15 | Final discussion | |||
| 17:30 | Close |
| Chair: Dr Moloy Das, Prof Tarv Dhanjal | Newcastle Upon Tyne, UK, Coventry, UK | |||
|---|---|---|---|---|
| 16:00 | Differentiating VT substrates: A mechanistic approach to ablation | Dr Johanna Tonko | London, UK | |
| 16:15 | Are all substrate mapping methods equally effective? | Mr Joseph Mayer | Stoke On Trent, UK | |
| 16:30 | Early experience of a RF/PF lattice catheter | Dr Vishal Luther | Liverpool, UK | |
| 16:45 | Debate: an endo-epi approach should be performed first-line for VT ablation. PRO | Prof John Silberbauer | Brighton, UK | |
| 17:00 | Debate: an endo-epi approach should be performed first-line for VT ablation. CON | Dr Gareth Padfield | Glasgow, UK | |
| 17:15 | Final discussion | |||
| 17:30 | Close |
| Chair: Dr Shamil Yusuf, Dr Shui Hao Chin | Coventry, UK, Leicester, UK | |||
|---|---|---|---|---|
| 16:00 | Outcomes in catheter ablation and conservative management after ICD therapies in patients with structural heart disease: a single-centre real-world experience | Timothy Jones | Southampton, UK | |
| 16:15 | HCM-SCD risk change and arrhythmic outcomes after mavacamten therapy in hypertrophic obstructive cardiomyopathy | Hou Mak | Newcastle Upon Tyne, UK | |
| 16:30 | Does the CARTOSOUND FAM automated algorithm generate a more accurate reconstruction of left atrial anatomy than conventional manual assessment of intracardiac | Mike Lawless | Middlesbrough, UK | |
| 16:45 | Pacing-induced severe functional mitral regurgitation after “ablate and pace” with a leadless pacemaker: reversal with endocardial resynchronisation | Thet Hnin | Middlesbrough, UK | |
| 17:00 | SCOPE-15: Syncope comorbidity outcomes and pacemaker evolution – a 15-year retrospective cohort study of ILR monitoring | Ana Correia | Chertsey, UK | |
| 17:15 | Fixation beats do not predict physiological conduction system capture in left bundle branch area pacing | Gareth Davies | Swansea, UK | |
| 17:30 | Close |